SkinHealth Systems Inc.

SkinHealth Systems Inc.

0.48
EUR
0.00
(0.00%)
-3.86EPS
80.01MMarket Cap
Nov 10Next Earn
SkinHealth Systems Inc.
GETTEX:V7A0
(Gettex)

Recent

price

0.48

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
17.91
26.57
18.99
50.94
49.59
60.45
53.99
47.6
45.34
Revenue per Share
-14.5
-0.38
-4.77
-74.18
5.99
-15.21
-4.7
-1.51
-4.45
Basic EPS, GAAP
-0.14
0.28
-1.98
-8.61
-16.81
1.32
1.51
5.12
2.6
Free Cash Flow per Basic Share
15.74
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.19
-4.78
40.15
25.27
9.66
8.29
9.58
8.54
Book Value per Share
- -
-25.52
-28.62
16.28
-0.59
-20.92
-19.08
-15.89
-15.53
Tangible Book Value per Share
6
6
6
5
7
7
6
6
6
Basic Weighted Avg Shares
112
167
119
260
366
398
334
301
290
Sales/Revenue/Turnover
8.96
8.08
-14.43
-15.35
-7.06
-32.89
-20.27
-6.92
-1.49
Operating Margin (%)
11
14
15
18
23
35
34
25
24
Depreciation Expense
- -
-2
-29
-379
44
-100
-29
-10
-28
Net Income, GAAP
3,270
- -
- -
- -
2.46
- -
- -
- -
- -
Effective Tax Rate (%)
-0.28
-0.98
-24.5
-145.63
12.09
-25.16
-8.7
-3.16
-9.8
Profit Margin (%)
- -
16
28
924
712
583
409
123
127
Working Capital
- -
181
216
743
747
748
563
250
260
LT Debt
- -
-1
-30
302
167
59
52
61
56
Total Equity
- -
- -
- -
- -
-2.54
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
5.82
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
18.84
-88.42
-52.34
-16.87
-43.89
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
129
107
107
LT Borrowings
240
241
242
LT Finance Leases
9
19
18
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
7
Market Capitalization
178
115
91

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
310
278
295
Cash, Cash Equivalents & STI
233
204
206
Accounts Receivable, Net
22
19
18
Inventories
48
48
47
Total Current Liabilities
186
155
168
Payables & Accruals
54
45
59
ST Debt
129
107
107
Deferred Revenue
1
1
1

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-242.62%
17.86%
Free Cash Flow
- -
116.39%
246.06%
Net Income, GAAP
- -
124.39%
-67.29%
Sales/Revenue/Turnover
- -
28.37%
-10.02%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
81
91
79
83
334
2025
70
78
71
82
301
2026
65
72
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.11
0.03
-2.95
-1.66
-4.7
2025
-1.61
3.13
-1.74
-1.27
-1.51
2026
-1.04
-0.41
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
The Beauty Health Company The Beauty Health Company (Nasdaq: SKIN), together with its subsidiaries, designs, develops, manufactures, markets and sells esthetic technologies and skincare products focused on non-invasive aesthetic treatments worldwide, including in the Americas, Asia-Pacific, Europe, the Middle East and Africa; the company's flagship HydraFacial system utilizes patented vortex-fusion technology to cleanse, extract, exfoliate and hydrate skin through customizable proprietary serums and boosters addressing concerns such as acne, fine lines, hyperpigmentation and dryness; complementary offerings include Syndeo delivery systems for personalized provider-consumer experiences, SkinStylus SteriLock Microsystem for microneedling and nanoneedling treatments targeting hypertrophic scars and acne in Fitzpatrick skin types I-III, Keravive peptide solutions and take-home sprays for scalp health optimization, single-use consumables comprising treatment tips, solutions and serums that represent over 70% of revenue, and the MyBeautyHealth mobile application enabling consumer loyalty points, personalized skin plans and provider connections. Founded in 1997 and headquartered at 2165 Spring Street in Long Beach, California, the company targets skincare professionals, medspas, salons and consumers seeking science-backed beauty health experiences in the consumer staples sector's household and personal products industry. Recent developments include the successful launch of HydraFillic with Pep9 Booster and Hydralock HA boosters driving 14% consumables growth and contributing to gross margin expansion to 64.6% in Q3 2025, substantial debt reduction of approximately $189 million in convertible senior notes through refinancing and repurchases to bolster the balance sheet with $219 million in cash equivalents as of September 30 2025, updated FY2025 guidance raising net sales projections to $293-$300 million and Adjusted EBITDA to $37-$39 million amid an active install base of 35,409 delivery systems, transition to a direct distributor model in China to streamline inventory and mitigate tariff exposure, and manufacturing optimizations alongside cost discipline yielding Adjusted EBITDA of $8.9 million in Q3 2025 despite softer device placements.

Company News

  • SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026

  • SkinHealth Systems Inc. (SKIN) Soars 9.0%: Is Further Upside Left in the Stock?

  • Niagen Bioscience (NASDAQ:NAGE) and Beauty Health (NASDAQ:SKIN) Head to Head Review

  • SkinHealth Systems Announces Reverse Stock Split

  • e.l.f. SKIN's Save Your e.l.f. Hypochlorous Mist Helps Soothe Stress in every e.l.f.ing mist-mergency

  • Hydrafacial Introduces HydraClear™ Treatment Booster to Clarify Blemish-Prone Skin

  • Contrasting Beauty Health (NASDAQ:SKIN) and Betterware de Mexico SAPI de C (NYSE:BWMX)

  • SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe

  • Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach

  • SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit

  • Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers

  • SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

  • SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored

  • Herbalife (NYSE:HLF) versus Beauty Health (NASDAQ:SKIN) Head to Head Comparison

  • SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript

  • Beauty Health Q2 Earnings Call Highlights

  • SkinHealth Systems Inc. (SKIN) Reports Q2 Earnings: What Key Metrics Have to Say

  • Earnings Preview: SkinHealth Systems Inc. (SKIN) Q2 Earnings Expected to Decline

  • SkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026

  • SkinHealth Systems Inc. (SKIN) Upgraded to Strong Buy: Here's Why